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Introduction 
The global community adopted a set of 17 Sustainable Development Goals (SDGs) on September 25, 5 
2015, to provide benchmark targets for global development between 2015 and 20301. These goals are 
intended to build on the momentum and enthusiasm generated by the Millennium Development Goals 
(MDGs)2, but also to reframe them within the context of myriad environmental and societal challenges 
inherent in achieving sustainable global development3,4. The Global Strategy for Women’s, Children’s, 
and Adolescents’ Health 2016–2030 further aims to position the global discussion of maternal mortality 10 
within a continuum of programs aimed at improving the health of women and children globally5.  
As the MDG era has now come to a close and the SDG era is beginning, it is imperative to provide a 
comprehensive account of global, regional, and national progress toward MDG 5. Such information is of 
crucial importance to identifying areas of success and remaining challenges, and helping frame policy 
discussions as we continue to prioritise maternal and reproductive health for women in the SDG era6. 15 
Whereas MDG 5 set a target reduction of 75% in the maternal mortality ratio (MMR; number of 
maternal deaths per 100,000 live births) between 1990 and 2015, SDG 3.1 sets a specific target for all 
countries to lower MMR to less than 70 by 2030. A secondary target of MDG 5, adopted in 2005, called 
for universal access to reproductive health care with named sub-targets for contraceptive prevalence, 
adolescent pregnancy, antenatal care coverage, and family planning services7, but notably not for other 20 
reproductive health services such as skilled birth attendance, in-facility delivery, or emergency obstetric 
care (EmOC) services. Because of its late addition to the MDG agenda, however, data collection systems 
have taken time to mature and reproductive health access has not been tracked as closely as maternal 
mortality. SDG 3.7 has continued the calls for universal access to sexual and reproductive health services 
by 2030.  25 
We have completed this study as part of GBD 2015, with the specific objective of ascertaining levels and 
trends in maternal mortality over the entire MDG period at the national, regional, and global levels. 
Relatedly, by also examining maternal mortality trends by age, cause, geography and timing of death, 
we seek to better understand trends in maternal mortality epidemiology and thus generate insight into 
drivers of progress—or lack thereof—toward achievement of MDG 5 and help frame discussions for 30 
monitoring of SDG 3.1 and 3.7.  Multiple previous analyses, including several completed as part of the 
Global Burden of Diseases, Injuries, and Risk Factors (GBD) collaboration, have sought to provide the 
best possible information on levels and trends in maternal mortality8–14. In dual recognition of both the 
importance and difficulty of accurately reporting on maternal mortality in many settings15,16, each has 
incorporated increasingly large and geographically precise datasets and utilized more advanced 35 
statistical models. In their latest iteration12, the World Health Organisation (WHO) methods have also 
now adopted a single model for all countries and computed statistical uncertainty intervals. Important 
differences remain, however, between WHO and GBD maternal mortality estimates that at times paint 
divergent pictures of levels and trends in maternal mortality globally and in many countries. The main 
differences now stem from data selection, quality appraisal, data processing, and adult mortality 40 
estimation rather than the statistical maternal mortality models themselves.  
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In this GBD 2015 report, we present the underlying data for 519 distinct geographic units in 195 
countries and territories, our methods for processing those data, the subsequent analytic approach, and 
findings on maternal mortality from 1990 to 2015. Published in 2012, GBD 2010 presented results for 
187 countries with a population greater than 50,000 in the year 2000.17 Collaborative teams completed 45 
subnational assessments for the United Kingdom, Mexico, and China for GBD 2013, expanding the 
number of geographies in the GBD analysis to 296.18–21 The value of subnational assessments to local 
decision-makers22 has led to expansion of subnational analyses in GBD 2015 to also include Brazil, India, 
Japan, Kenya, Saudi Arabia, South Africa, Sweden, and the United States. We expect subnational 
analyses for other countries will be added in future GBD iterations. The expansion of the geographical 50 
units in the GBD will continue in a way that will sustain comparability over time for the period 1990 to 
present and across all geographic entities. We have not included constant rate-of-change forecasts in 
this paper because, as part of the broader effort to quantify the population disease burden, we are 
developing a set of rigorous statistical models to forecast each component of the GBD—including 
maternal mortality—and we expect to be able to explore much more robust forecasts in the near future.  55 
As with all GBD revisions, the GBD 2015 study describes updated maternal mortality estimates for the 
entire time series from 1990 to 2015 based on newly identified data sources released or collected since 
GBD 2013. In response to published commentaries and unpublished seminars and communications on 
GBD methods, various methodological refinements have been implemented23,24. In addition, a major 
effort toward data and code transparency has been part of the GBD 2015 cycle. And as with each GBD 60 
cycle, the full time series published here supersedes prior GBD studies. This analysis explores global, 
regional, national, and subnational progress and seeks to identify correlates that help explain why some 
nations have seen great improvements in maternal health while others have stagnated and others still 
have worsened. These include examination of associations in national maternal mortality levels and 
trends with coverage of reproductive health interventions and Socio-Demographic Index (SDI).  65 
Methods 
Overview 
Maternal mortality is defined as a death that occurs to a woman as a direct result of obstetric 
complications or indirectly as a result of pregnancy-induced exacerbation of pre-existing medical 
conditions, but not as a result of incidental or accidental causes. To ensure internal consistency with all 70 
other causes of death, maternal mortality was again analysed as a component of the overall GBD study. 
Many of the analytic components are therefore shared with other causes, including methods of data 
source identification and cataloguing, data preparation, modeling platforms, and processing of results. 
Here we will focus on parts of the process that are unique, have been updated since GBD 2013, or are 
especially relevant to our analysis of maternal mortality. Figure 1 illustrates details of the analysis. 75 
General components are described in the appendix, in other reports in this issue, and have also been 
published previously10,25,26. This report follows the Guidelines for Accurate and Transparent Health 
Estimates Reporting (GATHER) guidelines proposed by WHO and others which provide 
recommendations on documentation of data sources, methods, and analysis27.  
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Maternal mortality estimation 80 
Geographical units of analysis  
Our analysis was completed separately for 519 unique locations in 195 countries and territories. This 
includes all 188 countries analysed in GBD 2013 as well as seven additional countries or territories, 
namely American Samoa, Greenland, Guam, Northern Mariana Islands, Puerto Rico, and the US Virgin 
Islands, where high-quality vital registration (VR) data were available. Of note, these territories were not 85 
included in the national totals for Denmark, the United Kingdom, or the United States, but were instead 
included in GBD 2013 regional totals. All 195 countries are hierarchically organized into 21 regions, each 
of which is nested in one of seven super-regions. Based on a combination of data availability and 
collaborator interest, we disaggregated GBD 2015 analyses into subnational units for a number of 
countries, including 26 states and one district for Brazil, 34 provinces and municipalities for China, 31 90 
states and union territory groupings for India that include 62 rural and urban units, 47 prefectures for 
Japan, 47 counties for Kenya, 32 states and districts for Mexico, 13 provinces for Saudi Arabia, nine 
provinces for South Africa, two regions for Sweden, 13 regions for the United Kingdom (Northern 
Ireland, Scotland, Wales, England, and nine sub-regions of England), and 51 states and districts for the 
United States. At the first subnational unit level, we have a total of 256 geographic units. In this paper 95 
we present results for countries and territories, regions, super-regions, SDI quintiles, and at the global 
level.  
Data input and processing 
The contents of the dataset used in our final model are shown in Table 1 and compared to those used by 
the recent WHO analysis12. The data coverage by location for all source types combined is mapped in 100 
Figure 2. We had 599 unique sources from data from 186 of 195 countries (95%), covering 12,052 site 
years, an increase of 71% from GBD 2013 when we had 7,056 total site years of maternal mortality data. 
The nine countries without maternal mortality data included Andorra, Angola, Equatorial Guinea, the 
Federated States of Micronesia, Marshall Islands, Samoa, Solomon Islands, Somalia, and Vanuatu. 
Maternal mortality data were also available for additional subnational locations in Mexico, China, the 105 
United Kingdom, Japan, the United States, Kenya, South Africa, India, Sweden, and Brazil. All data were 
stored in a centralized SQL causes-of-death (COD) database in three formats: number of deaths, cause-
specific mortality rate per capita (CSMR), and cause fraction (CF; proportion of all deaths due to 
maternal causes). 
Vital registration (VR) systems have been shown to underestimate maternal mortality, but the amount 110 
of underestimation varies by setting and may change over time22–24. We therefore used a method that 
maximizes the data-driven nature—and specificity—of our adjustments by systematically evaluating 
each underlying data source. We included all sources with population-level data on maternal mortality 
from each geography. We used a standardized process to identify, extract, and process all relevant data 
sources, including those from VR systems, verbal autopsy (VA) studies, maternal surveillance systems, 115 
national confidential enquiry reports, and sibling survival histories from health surveys and censuses 
(Figure 1, Step 1).  
Standardized algorithms were implemented to adjust for age-, year-, and geography-specific patterns of 
incompleteness and underreporting for VR, as well as patterns of misclassification of deaths in VR and 
VA sources (Figure 1, Step 2). These generalized algorithms were employed across all GBD causes and 120 
thus were able to capture trends in VR quality changes with respect to maternal mortality even in 
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locations where surveillance studies have not been completed25. Each code in ICD-coded VR datasets 
was uniquely assigned to a corresponding cause in the hierarchical GBD cause list. Codes used in tabular 
classification systems (e.g., ICD-9 BTL [Basic Tabular List], verbal autopsy, maternal surveillance systems) 
were likewise uniquely matched with a GBD cause. A proportion of deaths assigned to causes that 125 
cannot be underlying causes of death (garbage coded) were reassigned to maternal causes based on 
statistical redistribution packages, as described in the appendix. The net effect of data processing steps 
on VR across all locations and years combined was to increase maternal deaths by 168%. The net effect 
varied by geography and year even amongst those countries and territories with at least 10 years of 
data, ranging from <1% increase in Mongolia to a 9-fold increase in China. Final and raw VR data for 130 
each country and year are shown in the appendix, including proportion of all deaths assigned to garbage 
codes, and comparisons with WHO VR adjustments12. Figure 3 graphically illustrates the results of 
garbage code redistribution for maternal mortality at the global level. Distinct cause groupings, many of 
which are garbage codes, are shown on the left and the relative thickness of lines shows the proportion 
of all deaths from those codes that were subsequently mapped to corresponding maternal causes on 135 
the right. Note that by definition the “non-garbage” codes on the left map directly to maternal causes.  
Given their inconsistent use by VR systems, codes pertaining to HIV-related indirect maternal deaths 
were excluded at this stage in favor of a more comprehensive approach to estimating the impact of HIV 
on maternal death (see below for more details of HIV-related maternal mortality analysis). In addition to 
VR, we identified maternal mortality surveillance systems and published confidential enquiry (CE) 140 
studies identified via targeted web search and systematic review of national ministry of health websites. 
CE are specialised studies designed to investigate the number and circumstances of maternal deaths.  
Inclusion required a clear distinction identified between maternal and incidental deaths during 
pregnancy. As with VR systems, HIV-related indirect maternal deaths were excluded from surveillance 
datasets at this stage (see below for more details) but otherwise were unadjusted. Single-year sibling 145 
history and survey data derived from health surveys and censuses was processed as in GBD 2013, using 
Gakidou-King weights to adjust for survivor bias and only retaining data from older surveys when years 
of death overlapped28 (Figure 1, Step 3).  
Our general approach to quantifying the role of HIV in maternal mortality is unchanged from GBD 2013 
and again involved comprehensive estimation of the population-attributable fraction (PAF) of maternal 150 
mortality to HIV10 (Figure 1, Step 4). Given the increased baseline mortality of those with advanced HIV, 
this approach has helped distinguish between deaths in HIV-positive women that were caused by 
pregnancy and those for which the pregnancy was incidental to their death. A detailed description of the 
GBD 2013 approach and updates is in the appendix. An updated systematic literature search completed 
on July 20, 2015, did not reveal any new sources to inform either our meta-analysis of relative risk of 155 
pregnancy-related death for HIV-positive versus HIV-negative women or our analysis on the proportion 
of pregnancy-related deaths in HIV-positive women that are maternal (versus incidental). HIV 
prevalence in pregnancy, approximated as the ratio of live births in HIV-positive to HIV-negative women, 
was updated using our modified EPP-Spectrum model. We also made two important improvements to 
overall HIV mortality estimation, both of which impacted our HIV-related maternal mortality estimates. 160 
First, to improve the internal consistency of estimates developed for countries with generalised HIV 
epidemics, we modified EPP-Spectrum to improve how it integrates ART-dependent HIV progression and 
mortality data from published cohort studies and combined these findings with results derived from 
statistical examination of how all-cause mortality relates to crude HIV death rate. Second, in recognition 
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of the fact that HIV mortality rivals or exceeds that of high mortality events (referred to as “fatal 165 
discontinuities” in GBD 2015) such as war and natural disaster in many locations—and that such 
discontinuities have significant detrimental effects on statistical mortality models—all of our maternal 
mortality data were processed to ensure incidental HIV deaths were excluded prior to modeling. We 
processed sibling history and census data to exclude incidental HIV deaths using PAFs calculated above 
for each geography, age group, and year. This is analogous to the HIV-correction process used in GBD 170 
2013 except that the correction was performed on the data itself rather than the preliminary model 
results. To ensure consistency between all data sources, we also applied PAFs to all VR, VA, and 
surveillance data to add back the corresponding number of HIV-related indirect maternal deaths in each 
of those sources. Finally, to reduce error introduced by large stochastic fluctuations and upward bias 
introduced by data that have a value of zero , we processed all data of all specifications using Bayesian 175 
noise-reduction algorithms – see appendix for more details (Figure 1, Step 5). Zeros are problematic 
because the log of zero is undefined, so all zeroes would otherwise be ignored by log-based statistical 
mortality models.  
Modelling overall maternal mortality 
We again modeled overall maternal mortality using cause-of-death ensemble modeling (CODEm), which 180 
was developed for GBD 201029 and is described in detail in the appendix (Figure 1, Step 6). CODEm runs 
four separate models, including natural log of age-specific death rates and logit-transformed cause-
fractions in each of linear and spatiotemporal Gaussian process regression (ST-GPR) formats. Using 
multiple holdout patterns and cross-validation testing, every combination of covariates was tested. 
Models where regression coefficients met requirements for direction and significance were then ranked 185 
on the basis of out-of-sample predictive validity performance through multiple iterations of cross-
validation testing. We then generated a series of ensemble models with a range of weightings such that 
top-performing component models contributed the most to the final prediction. We ran two separate 
CODEm models, one for countries with extensive complete VR representation and another for all 
countries combined. The purpose was so that heterogeneous data from countries without extensive 190 
complete VR representation would not inflate the uncertainty interval for countries with extensive and 
complete cause-specific death data. Results from the former model were used for all geographies with 
extensive complete VR representation; results for all other geographies were from the latter model. 
Predictive covariates were specified with respect to required directionality and significance level of 
regression coefficients (see appendix for full details). Three hierarchical covariate levels reduce the 195 
combinatorial burden on CODEm. Covariates with strong or causal association were assigned to level 1; 
those that are ecologically related were assigned to level 2; and those where association is suspected 
but not proven at the population level were assigned to level 3. We largely used the same covariates as 
in GBD 2013, including age-standardised fertility rate, total fertility rate, years of education per capita, 
lag-distributed income (dollars per capita), neonatal mortality rate (per 1,000 live births), HIV mortality 200 
in females of reproductive age, and the coverage proportion of one visit of antenatal care, four visits of 
antenatal care, skilled birth attendance, and in-facility delivery. Several new covariates were introduced 
in this analysis in recognition of their potential relationship to maternal mortality, all of which were 
specified as level 3. Obesity prevalence was added to help reflect the added complexity of care and 
heightened risk of maternal complications in those who are obese30,31. Mortality death rate from fatal 205 
discontinuities, a covariate that aggregates the effects of war, famine, and natural disaster, was 
introduced to help inform maternal mortality estimates in geographies where demographic shocks have 
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led to interruption of vital statistics and where health systems are also hypothesized to have 
deteriorated32,33. Hospital beds per 1,000 population was added based on the hypothesis that it may be 
a proxy for the availability of basic emergency obstetric care34. Socio-Demographic Index (SDI), based on 210 
principal component analysis of fertility, maternal education (years per capita), and lag-distributed 
income (International $ per capita), was added as a covariate to all CODEm models in GBD 2015. The 
root-mean standard error of the top-performing ensemble model was 0.318 for the DR model and 0.553 
for the global model. In-sample and out-of-sample data coverage was 99.6% and 99.3%, respectively, for 
the DR model. It was 98.3% and 97.7%, respectively, for the global model. The relative contributions of 215 
each of the covariates and sub-model performance for all component models in the top-performing 
CODEm ensemble are shown in Appendix Table 4. 
Modelling underlying etiology and timing of maternal mortality 
Our approach for quantifying underlying etiology and timing of maternal deaths was largely unchanged 
from GBD 2013, although in some cases we changed cause names to better reflect the ICD-9 and ICD-10 220 
codes contained therein. ICD-9 and ICD-10 codes corresponding to each category are in the appendix. 
We examined six groups of direct obstetric causes including maternal hypertensive disorders; maternal 
haemorrhage; maternal abortion, miscarriage, and ectopic pregnancy; maternal obstructed labor and 
uterine rupture; maternal sepsis and other maternal infections; and other maternal disorders. Two 
categories of indirect obstetric causes included maternal deaths aggravated by HIV/AIDS and indirect 225 
maternal disorders. Late maternal deaths occurring between 42 days and 1 year after the end of 
pregnancy were estimated as a separate etiology (ICD-10 code = O96). There are two notable 
differences between the GBD and ICD-MM classification systems, neither of which are new in this study, 
but nonetheless warrant mention in that they each reflect important clinical aspects of pregnancy 
complications. First, the GBD has grouped uterine rupture with obstructed labor rather than maternal 230 
haemorrhage, in recognition that a majority of uterine rupture cases are secondary to inadequately 
addressed or prolonged obstruction of labor. Second is the combining of abortion, ectopic pregnancy, 
and miscarriage into a single cause. Although there are important differences between them, safe 
treatment is similar for each condition during early pregnancy (e.g. medication, potentially dilation and 
evacuation) and in managing life-threating complications such as infection and bleeding (e.g. infection, 235 
bleeding) which require prompt evaluation, diagnosis, and often emergency surgical intervention. We 
also examined four distinct time windows of maternal death. In addition to late maternal deaths, we 
estimated deaths occurring during the antepartum period (prior to onset of labor), intrapartum and 
immediate postpartum (onset of labor up to <24 hours after delivery), and early and delayed 
postpartum (24 hrs to 42 days after delivery). We analysed late maternal death as both a timing 240 
category and as a distinct etiology because the underlying causes of late maternal deaths are not 
specified in most data sources.  
Systematic literature reviews identified studies that examined underlying causes and timing of maternal 
deaths (Figure 1, Step 7). We extracted additional information from specialized studies such as 
confidential enquiries and maternal mortality review boards that were obtained from targeted web 245 
searches or from correspondence with GBD collaborators. We supplemented etiology models with 
cause-specific data from the causes-of-death (COD) database. Of note, our criteria for including data 
from the COD database was modified from GBD 2013 to include all data from any source where specific 
sub-causes were coded rather than limiting to only those sources where the complete complement of 
sub-causes were included. This change had the effect of dramatically increasing the size of our analytic 250 
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dataset with respect to time and geography. Late maternal death data from the COD database were 
limited to those location-years where at least 0.5% of all maternal deaths in raw VR data files were 
coded to late maternal deaths as this was the lowest proportion reported in any surveillance studies35. 
Only 39 countries met these criteria with variable times in which they began coding late maternal 
deaths. Timing models were additionally supplemented with temporal information on pregnancy-255 
related deaths from DHS maternal mortality modules. These data only reported on antepartum, 
intrapartum, and postpartum death.  
In order to maximize the volume and geographic distribution of data to inform etiologic attribution, we 
again modeled the proportion of deaths due to each etiology and timing category using DisMod-MR 2.1 
(Figure 1, Step 8). The exception was HIV-related maternal mortality, where the proportion was 260 
estimated using the PAF approach described above (Figure 1, Step 9). All data for etiology and timing 
models where late maternal death was excluded were statistically cross-walked within DisMod-MR 2.1 
to the reference definition where late maternal death is included. Analytic details of DisMod-MR have 
been previously described10. Further description, including details about updates contained in DisMod-
MR 2.1 and statistical cross-walks, are also included in the appendix. To correct for ascertainment bias 265 
inherent in the introduction of late maternal death partway through the MDG period, we corrected 
overall maternal mortality estimates for the systematic exclusion of late maternal death in those 
location-years where it was not coded (Figure 1, Step 10). Selection criteria for identifying those 
geographies and years to be corrected is described above. Geographies where coding of late maternal 
deaths was introduced partway through the time period were only corrected for the years prior to 270 
introduction. Age-, year-, and geography-specific proportions predicted by DisMod-MR 2.1 for 
underlying etiologies and timing were then applied to the overall maternal mortality model developed in 
CODEm (Figure 1, Step 11). 
Ensuring consistency with all other causes of death 
Another crucial strength of the GBD approach to maternal mortality is that all results are internally 275 
consistent with all other specific causes of death (Figure 1, Step 12). CoDCorrect is a process that 
employs a simple algorithm to scale all cause-specific deaths from all causes for each age-group, sex, 
year, and location and thereby ensures that the sum equals total all-cause mortality. For maternal 
mortality, it further scaled the sum of all etiology-specific and timing-specific estimates to equal the 
total for all maternal mortality. Further details on CoDCorrect and its implementation are described in 280 
the appendix.  
Age groups and fertility 
Previous analyses have truncated evaluation of maternal mortality at 15 to 49 years. Doing so ignores 
the non-trivial number of pregnancies and deaths occurring in those less than 15 and more than 50 
years old36. Deaths in these age groups are routinely coded in our data sources, so for the first time, we 285 
have expanded the age range of our maternal mortality analysis to include all five-year age groups from 
10 to 54 years in GBD 2015. To facilitate calculation of MMR in these age groups, our demographic 
analysis included expansion of UN Population Division estimates of age-specific live births to include 10-
14 years and 50-54 years (Figure 1, Step 13). The appendix provides more detail on fertility estimation in 
these age groups and a table of age-specific live births for all locations.  290 
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Uncertainty analysis 
We report 95% uncertainty intervals (UIs) for all estimates. UIs include uncertainty introduced by 
variable sample sizes, data adjustments for all-cause mortality sources, and cause-specific model 
specifications and estimation. In CODEm, after a model weighting scheme has been chosen, each model 
contributes a number of draws proportional to its weight such that 1,000 draws are created. The mean 295 
of the draws is used as the final estimate for the CODEm process and 95% UI are created from the 0.025 
and 0.975 quantiles of the draws. In DisMod-MR 2.1, uncertainty is calculated by sampling 1,000 draws 
from the posterior distribution of each most-detailed geography, age group, and year. UIs for underlying 
etiologies and timing are propagated from the combination of CODEm and DisMod-MR 2.1 draws. We 
propagated uncertainty into all the final quantities of interest at all levels of geographic, temporal, and 300 
age-specific aggregation assuming no correlation between them. 
Analysis of levels and trends 
MMR, annualised rate of change, and reporting metrics 
We report number of deaths and maternal mortality ratio (MMR; number of deaths per 100 000 live 
births) for ages 10 to 54 inclusive. We calculated MMR for each five-year age group separately using 305 
age-specific live births (Figure 1, Step 14). We calculated annualised rate of change (ARC) using the two-
point continuously compounded rate-of-change formula37 in each geography separately for 1990 to 
2000, 2000 to 2015, 1990 to 2015, and all single years throughout the time period. ARC examination 
reveals overall trends, highlights periods of acceleration (or deceleration) in improvement, and permits 
identification of those countries that likely achieved MDG 5.  310 
Drivers of change in the MDG era, coverage target setting for SDGs 
For GBD 2015, we completed two additional analyses to systematically describe drivers of levels and 
trends in maternal mortality. First, we examined the relationship between MMR and the Socio-
Demographic Index (SDI), a summary indicator derived from measures of income per capita, educational 
attainment, and fertility using the Human Development Index methodology38. The SDI has an 315 
interpretable scale: zero represents the lowest income per capita, lowest educational attainment, and 
highest TFR observed across all GBD geographies from 1980 to 2015 and one represents the highest 
income per capita, highest educational attainment, and lowest TFR. We then used spline regression to 
calculate the average relationship between MMR and SDI, thereby facilitating further evaluation of 
geographic and temporal MMR trends. Further details of SDI development and spline regressions are in 320 
the appendix. We then used the average relationship between SDI and MMR to calculate observed 
minus expected (O-E) MMR ratio and O-E ARC (from 2000 to 2015), respectively, to show average 
patterns that can help benchmark a country against other countries and provides insights into whether 
or not public action or other factors have been leading to narrowing—or growing—inequalities since the 
MDG declaration. , Second, to capture how improvements in women’s access to the specific modes of 325 
reproductive health care may alter the average relationship observed between SDI and MMR, we also 
examined the relationship between MMR and coverage of one visit of antenatal care (ANC), four ANC 
visits (a proxy for more comprehensive care), in-facility delivery (IFD), and skilled birth attendance (SBA) 
by calculating the average coverage of each over different MMR ranges.  
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Role of funding source 330 
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or 
writing of the report. The authors had access to the data in the study and had final responsibility for the 
decision to submit for publication. 
Results 
Global and country-specific maternal mortality 335 
Global maternal deaths decreased slightly from 390,185 (95% UI: 365,193– 16,235) in 1990 to 374,321 ( 
351,336 – 400,419) in 2000 before dropping to 275,288 ( 243,757– 315,490) in 2015 as shown in Figure 
4. The overall decrease from 1990 to 2015 in global maternal deaths was roughly 29% and the decrease 
in MMR was 30%. Results for all specific geographies in the GBD hierarchy are shown in Table 2. MMR 
followed a similar trend to overall maternal deaths. It was 282 (264 – 300) in 1990, 288 (270 – 308) in 340 
2000, and decreased to 196 (173 – 224) in 2015. Global ARC was -1.5% (-2.0 – -0.9%) across the entire 
MDG period from 1990 to 2015. It was initially relatively flat at 0.21% (-0.46 – 0.87%) from 1990 to 2000, 
but accelerated significantly after the Millennium Declaration to be -2.6% (-3.4 – -1.7%) from 2000 to 
2015. Looking at single-year ARC, we see the global acceleration began in the year 2001 and has 
continued accelerating until 2007–2008, after which the rate of improvement has slowed.  345 
Geographic differences in maternal mortality are readily apparent. As shown in the map from 1990 in 
Figure 5a, 60 countries had an MMR greater than 200, 40 countries had an MMR of greater than 400, 
and 15 greater than 600. Only 1 country—Burundi —had an MMR greater than 1,000. MMR was less 
than 70 in 93 countries at that time. A subset of 50 had MMR of less than 30, and 28 were less than 15. 
By the year 2015, as shown in Figure 5b, 122 countries had an MMR of less than 70, and 49 had an MMR 350 
of less than 15, including Saudi Arabia, all countries in central Europe, and all high- income locations 
with the exception of the United States, Argentina, Brunei, Chile, and Uruguay. Several other countries 
in North Africa and Middle East along with the United States, Armenia, Azerbaijan, Bulgaria, Chile, China, 
Costa Rica, Kazakhstan, Puerto Rico, Romania, Russia, Tajikistan, Thailand, Turkmenistan, Ukraine, 
Uruguay, Uzbekistan, and Vietnam had MMR between 15 and 30. Unfortunately, there were still 24 with 355 
MMR of greater than 400, 8 greater than 600, and still one—Central African Republic--greater than 
1,000. Of those greater than 600, Sierra Leone, Afghanistan, and Central African Republic actually 
worsened, with ARC from 1990 to 2015 of 2.7% (-1.3 – 6.3%), 0.34% (-2.1 – 2.7%), and 0.08% (-5.5 – 
4.9%), respectively. Of those with an MMR higher than 400 in 1990, Burundi and Equatorial Guinea 
improved substantially by 2015 with total improvements of -4.3% (-8.7 – .3%) and -4.2% (-9.6 – 3.9%), 360 
respectively.  
MDG 5 achievement 
In order to achieve the primary objective of MDG5, ARC must have met or exceeded an average of -5.5% 
over the entire time period from 1990 to 2015. Based on this metric, a total of ten countries likely 
achieved MDG5, including Iceland, Jordan, Maldives, Belarus, Morocco, Romania, China, Turkey, Poland, 365 
and Estonia. A number of other countries achieved this rate of improvement at some point during the 
MDG period. From 2000 to 2015, a total of 24 countries exceed ARC of -5.5%. Many countries, despite 
not achieving the ambitious MDG 5 target of a 75% reduction, actually have been experiencing steady 
declines in maternal mortality for quite some time. One hundred forty-eight of 195 countries and 
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territories saw their peak MMR occur before the year 2000, with an additional 21 occurring by the year 370 
2005. Maternal mortality increased in 26 countries between 1990 and 2015.  
The relationship between MMR, SDI, and reproductive health services 
Figure 6 shows global and regional-level MMR and SDI from 1990 to 2015. The black convex line 
represents the average relationship between MMR and SDI over the time period and is the basis of 
“expected” MMR. Maternal mortality in the lowest SDI quintile improved the least, with ARC of only -375 
0.97% (-1.8 – -0.001%) from 1990 to 2015, and the low-middle SDI quintile was the next slowest with an 
ARC of -2.1% (-2.8 – -1.1%). The proportion of all maternal deaths occurring in the bottom two SDI 
quintiles increased from roughly 68% in 1990 to more than 80% in 2015. The middle SDI quintile 
improved the fastest with ARC of -3.2% (-3.8 – -2.6%) over the entire time period (Table 2). Each colored 
symbol represents a successive year from 1990 to 2015 for the global level and GBD regions. At the 380 
global level, MMR in 2015 was more than double what would have been predicted solely by average SDI. 
This was following a period from 1990 to 2000 where global MMR improved more slowly than would 
have been expected based on SDI improvement and a period of faster-than-expected MMR 
improvement from 2000 to 2015. Based on the expected relationship between MMR and SDI, reaching 
the SDG 3.1 achievement threshold of MMR 70 would require an SDI of 0.65, corresponding to an 385 
average income of roughly $9,442 per capita, 8.2 years of education, and total fertility rate (TFR) of 2.5. 
Not all countries may be able to achieve that level of income, however, but education and fertility 
reduction efforts may still be compatible with reaching this SDI level. If all women were to complete a 
full 12 years of education and TFR of 2.7, an SDI of 0.65 would on average be associated with income of 
$3,214 per capita. If TFR were to decrease further to the population replacement rate of to 2.0 and 390 
education were 12 years, this SDI level would only require an annual income of $2,648 per capita.  
MMR and SDI both improved between 1990 and 2015 in almost all regions, but MMR did not universally 
track with SDI over the entire time period in any single region. East Asia has had the lowest O-E MMR 
ratio since 2011, a period in which it has consistently been less than 0.4 of expected. Australasia has also 
had consistently lower MMR than would be predicted on the basis of SDI, with O-E MMR ratio ranging 395 
from 0.54 in 1990 to 0.71 in 2015. In addition to East Asia and Australasia, several other regions have 
consistently had lower MMR than would have been expected by SDI, including central Asia, central 
Europe, eastern sub-Saharan Africa, Western Europe, and high-income Asia Pacific. Southern Latin 
America and North Africa and the Middle East both had lower than expected MMR in 1990 when both 
had O-E MMR ratios of <0.7, but improvement has not kept pace with SDI gains in either region: by 400 
2015, O-E MMR ratios were 2.23 and 1.41, respectively. Central sub-Saharan Africa has been an 
exception in multiple ways. In addition to having the highest MMR of any region in 2015, MMR 
worsened from 1990 to 2015. Despite maternal mortality being high in central sub-Saharan Africa, it was 
still lower than would have been expected until 2014 because SDI is still so low in that region and has 
improved only slowly.  405 
O-E MMR ratio has consistently been 1.25 or more in a larger number of regions, including the 
Caribbean, Eastern Europe, high-income North America, Oceania, South Asia, Southeast Asia, and 
southern sub-Saharan Africa. Andean Latin America had periods of rapid improvement in MMR during 
the early 2000s that exceeded that expected based on SDI. Unfortunately, MMR reductions there have 
slowed considerably since then, to the point where O-E MMR ratio was 1.41 in 2015. Improvements in 410 
Eastern Europe have been faster than SDI after the year 2000, but MMR improvement in the remaining 
regions has continued to be slower than expected on the basis of SDI. Southern sub-Saharan Africa and 
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the Caribbean had the highest O-E MMR ratios of any regions at 3.57 and 3.71, respectively, in 2015, but 
both have had recent periods of MMR improvement that were much more rapid than expected on the 
basis of SDI. These trend reversals began in 2006 and 2007, respectively. South Asia and Southeast Asia 415 
are unique in that while both have made dramatic gains in terms of SDI and MMR, the difference 
between observed and expected MMR based on SDI remained the same.  
Even within regions, the degree to which MMR diverged on the basis of SDI varied. For each country, we 
calculated observed ARC minus expected ARC (O-E ARC) on the basis of SDI change from 2000 to 2015 
(Figure 7). There were a total of 60 countries where O-E ARC was faster than would have been expected 420 
based on SDI alone, and 25 of these had ARC at least 1.5% faster than expected. Within South Asia, 
Bangladesh has improved faster than expected while Nepal, Bhutan, and India all had slower MMR 
reductions. Of the countries in Southeast Asia, Cambodia and Laos have improved much faster than 
expected while Thailand, Philippines, and Malaysia have not. In sub-Saharan Africa, Namibia, Malawi, 
and Burundi were all more than 1.5% faster than expected, but ARC in most of the countries of eastern 425 
and western sub-Saharan Africa exceeded SDI-based expectations. In contrast, only Gabon in central 
sub-Saharan Africa reduced MMR as rapidly as expected, with Democratic Republic of the Congo and 
Equatorial Guinea both more than 3% slower. A total of 93 countries had O-E ARC of 1.5% or more, and 
there were 17 countries where O-E ARC was greater than 5%.  
To begin exploring the hypothesis that MMR improvements are related to coverage of specific modes of 430 
reproductive health care, we examined the relationship between MMR and coverage of one visit of 
antenatal care (ANC), four ANC visits, in-facility delivery (IFD), and skilled birth attendance (SBA) over 
the period from 1990 to 2015 (Table 3). We found that, on average, countries with an MMR of less than 
15 had 98% coverage of one ANC visit, 95% of four ANC visits, 97% of IFD, and 99% of SBA. Those with 
an MMR of 70—the SDG 3.1 target for all countries—have roughly 91% coverage of one ANC visit, 78% 435 
of four ANC visits, 81% of IFD, and 87% of SBA. This is in contrast to those countries with an MMR 
around 200 where there is an average of 84% coverage of one ANC visit, 61% of four ANC visits, 63% of 
IFD, and 70% of SBA, and those locations with an MMR over 500 where coverage of all services was low, 
including just 76% coverage of one ANC visit, 45% of four ANC visits, 41% of IFD, and 48% of SBA. 
Comparable datasets were not available to examine the relationship between MMR and coverage of 440 
either emergency obstetric care (EmOC), distance to obstetric care, post-natal care coverage, or family 
planning services such as modern contraception and access to safe abortion services.   
Age pattern of maternal mortality and fertility 
The risk of maternal mortality increases dramatically with age but decreased significantly in almost all 
age groups from 1990 to 2015 (Figure 8). At the global level in 2015, MMR in 10–14 year olds girls was 445 
278 (229 – 339). MMR then decreased and was lowest in women from 15–29 years old before increasing 
dramatically to 1,832 (1,284 – 2,746) in 50- to 54-year-olds (not shown on graph). While the largest 
number of births still occur amongst women between the ages of 20 and 29 years (55% of total), there 
has been a decrease in adolescent fertility and a net shift in births to older women (Appendix Table 11 
of live births). In 1990, 23.3 million (17% of total) live births occurred in those under the age of 20, and 450 
0.58 million (0.42% of the total) were to girls aged 10-14 years. In 2015, 19.4 million (14% of total) births 
were in those 10 to 19 years old, but there were still 0.48 million (0.34% of total) to girls under the age 
of 15 years. In contrast, the absolute number of annual births to women ages 35 and older increased 
from 16.1 million (12% of total) in 1990 to 18 million (13% of total) in 2015. ARC in MMR among 10- to 
 12 
19-year-olds from 2000 to 2015 was -2.3 (-3.3 – -1.2), which was slower than the global ARC in MMR for 455 
all ages combined. 
Cause pattern of maternal mortality 
Although the risk of death from all causes increases with age, a majority of deaths still occur in younger 
women and the absolute numbers of deaths from all causes except HIV are higher in younger age groups 
(Figure 9a-c). Direct obstetric causes accounted for approximately 86% of all maternal deaths at the 460 
global level in 2015, led by maternal haemorrhage, maternal hypertensive disorders, and other maternal 
disorders. This is down only slightly from 1990 when direct complications accounted for 87% of all 
maternal deaths. Other maternal disorders decreased the most of all etiologies between 1990 and 2015, 
from a total of 74,299 (61,159 – 89,653) deaths in 1990, down to 32,734 (26,256 – 40,507) deaths in 
2015. Maternal abortion, miscarriage, and ectopic pregnancy, and maternal sepsis and other maternal 465 
infections were the etiologies with the next largest declines between 1990 and 2015. Indirect maternal 
disorders increased in importance from 1990 when they caused 42,246 (32,355 – 54,032) deaths 
(approximately 11% of total) to 2015 when they caused 33,108 (25,463 – 43,344) (approximately 12% of 
total). HIV-related maternal deaths were responsible for a portion of the increase in indirect maternal 
deaths, rising from 754 (433 – 1,095) globally in 1990, peaking in the year 2000, and coming down to 470 
2,322 (1,394 – 3,337) in 2015; this was 0.84% of overall maternal mortality in 2015. 2,181 (1,306– 3,174) 
of HIV-related maternal deaths were in sub-Saharan Africa in 2015, roughly 1.6% of the total there. 
Overall, the contribution of HIV to overall maternal death was quite small, but there are a large number 
of pregnant and postpartum women dying from complications HIV/AIDS. If we include incidental HIV 
deaths during pregnancy from our PAF analysis, a total of   20,180 (12,120 – 29,005) HIV-positive women 475 
died while pregnant or postpartum in 2015. (Appendix Table 10 shows etiology-specific maternal deaths 
for all GBD locations.) 
Changing cause pattern by age 
The age pattern for underlying maternal mortality etiologies in 2015 (Figure 9d) shows that in the 
youngest age groups, maternal haemorrhage and maternal hypertensive disorders are the dominant 480 
causes, together accounting for over 50% of all maternal deaths. While the comparative risk associated 
with maternal hypertensive disorders decreases with age, haemorrhage actually peaked in importance 
in the 35 to 39 years old. The contribution of most other etiologies of maternal death also increased 
with age, especially other direct maternal disorders and the combined category of abortion, ectopic 
pregnancy, and miscarriage. Late maternal deaths decreased steadily in importance from 1990, when 485 
8,460 (5,792 – 11,935) late maternal deaths occurred, to 2015, when 6,711 (4,335 – 9,996) occurred, 
and still was the time period with the smallest absolute number of deaths (Appendix Table 11 of timing 
deaths). The antepartum and postpartum periods were the periods with the largest numbers of deaths 
in 2015 at 101,774 (88,185 – 117,570) and 85,686 (72,956 – 101,862), respectively. The age pattern 
showed that the proportion of postpartum deaths peaked in the youngest age groups while intrapartum 490 
and antepartum deaths were more important in those over the age of 35 years (Appendix Figure 2). If 
we look at the change in underlying etiology patterns as predicted by SDI (Figure 10), we see that in the 
lowest SDI countries, maternal mortality is dominated by maternal haemorrhage. In high-SDI 
geographies, in contrast, the etiology pattern changes dramatically to one where other direct maternal 
disorders, indirect maternal disorders and abortion, ectopic pregnancy, and miscarriage are the most 495 
important causes of maternal death. In middle SDI countries, the epidemiological profile is even more 
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The overall change from 1990 to 2015 in global maternal deaths was roughly -29% and in MMR -30%, 
both of which were well short of the MDG 5 goal of -75%. Global maternal deaths were largely 
unchanged from 1990 to 2000, decreasing only slightly from 390,185 (365,193 – 416,235) in 1990 to 
374,321 (351,336 – 400,419) in 2000. Progress in MMR during the 1990s was also virtually undetectable 
when global ARC was only 0.21% (-0.46 – 0.87). This was 4.1% slower than would have been expected 505 
on the basis of SDI alone. After the Millennium Declaration, maternal mortality improvements 
accelerated. In 2015 there were 275,288 (243,757 – 315,490) maternal deaths, and average global ARC 
in MMR from 2000 to 2015 was -2.6% (-3.4% – -1.7%), although even with acceleration progress was 
1.8% slower than would have been expected on the basis of SDI improvements alone.  
Only ten countries achieved MDG 5 based on this analysis, including Iceland, Jordan, Maldives, Belarus, 510 
Morocco, Romania, China, Turkey, Poland, Estonia. Although overall progress has been slow during the 
MDG era, recent accelerations mean there are an additional 24 countries where ARC has met or 
exceeded the MDG 5 achievement rate between 2000 and 2015. There was significant variability in 
MMR throughout the world in 2015, ranging from a low of 0.8 (0.6 – 0.9) in Iceland to a high of 1,074 
(215 – 2857) in Central African Republic. One hundred twenty-two of 195 countries had MMR in 2015 515 
that is already less than the SDG 3.1 goal of 70.  
Impediments to MMR reduction are multifaceted and variable; many are also well-conceptualised 
through the lens of our SDI analysis. First, slow improvement in the two lowest SDI quintiles is one of the 
primary reasons that maternal mortality reduction has been slower than expected at the global level. In 
1990, these two quintiles collectively accounted for 68% of maternal mortality, but by 2015, increased 520 
to more than 80% of the global total. Part of the reason is that high adolescent fertility rates in these 
locations, coupled with comparatively slow improvement in adolescent MMR, led to concentration of 
maternal mortality burden in young women and girls and higher total fertility in these populations. 
Second, some middle SDI locations may be experiencing a period of inertia where progress is stalling 
because health systems have not evolved to meet the challenge of identifying and managing high-risk 525 
pregnancies and efficiently responding to rapid clinical deterioration. Middle SDI geographies have 
historically had a higher proportion of cases due to conditions such as hypertensive disorders of 
pregnancy and other direct maternal disorders (e.g. cardiomyopathy and embolism). Maternal 
haemorrhage also evolves with increasing SDI because, as increased IFD and SBA lead to near universal 
active management of the third stage of labor, an increasing proportion of remaining haemorrhage 530 
cases—especially those that result in death—will be due to intractable uterine atony or placental 
disorders, both of which require high levels of performance and responsiveness from horizontally-
integrated health systems39,. This treatise is supported by the observation that many of the geographies 
that improved more rapidly than would have been expected after 2000 were also the biggest recipients 
of Development Assistance for Health (DAH),40 funds that are often directed toward strengthening 535 
health systems, while many of those that have improved more slowly than expected have suffered from 
epidemics, natural disasters, and armed conflicts that impair the function of health systems and the 
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willingness or ability of women to seek care. Third, within any given geography, heterogeneous or 
slower-than-expected MMR improvements may be related to uneven ramp-up of coverage for specific 
modes of reproductive health care – antenatal care (ANC), in-facility delivery (IFD), skilled birth 540 
attendance (SBA), family planning services, emergency obstetric care (EmOC), and post-natal care – that 
are all known to decrease the risk of bad pregnancy outcomes41,42. Indeed, increasing utilization of 
reproductive health services was one of the driving factors behind establishment of the Janani Suraksha 
Yojana (JSY) conditional cash transfer program in India. JSY has been quite successful at increasing 
reproductive health care services, but even despite its popularity this program has not been as effective 545 
at reaching poor rural women, the sociodemographic group that is already at highest risk of adverse 
pregnancy outcomes43. In addition to the JSY program in India, other countries such as Nepal, Mexico, El 
Salvador, Honduras, Guatemala, Uruguay, and Brazil have also had success in encouraging use of 
reproductive care services44,45, so this may be a viable option for countries seeking to increase women’s 
utilisation of reproductive health care services. Fourth, the highest SDI geographies are likely also 550 
experiencing a confluence of factors leading to higher-risk pregnancies and subsequently higher-than-
expected MMR, namely delay of fertility to older ages and a corresponding increase in the proportion of 
pregnant women with non-communicable diseases (NCDs). Other direct maternal disorders is the 
dominant cause of maternal death in high SDI locations, driven by cardiomyopathy and obstetric 
embolism, both of which are of higher risk in older women and those with preexisting conditions such as 555 
hypertension, obesity, and diabetes46,47. If the trend of increasing NCDs continues and, barring any 
breakthrough in preventing such complications, we may reasonably expect to see MMR increases begin 
to emerge in other geographies besides those in the highest SDI.  
Because of the importance of reproductive care coverage in overall reproductive health, and to help 
guide specific coverage targets for achieving SDG 3.1 and 3.7, comparable metrics and monitoring on 560 
coverage of all of these reproductive health services should be integrated into regular progress reports 
at the global, regional, national, and subnational levels, including the development of comprehensive 
strategies to reach those targets. Our analysis found that an MMR of 70 is expected with an SDI level of 
0.65, which corresponds to average income of $2,648 per capita, a TFR of 2.0, and completing 12 years 
of education, so even lower income countries may have a path to SDG 3.1 attainment. An MMR of 70 is 565 
also associated with approximately 91% coverage of one ANC visit, 78% of four ANC visits, 81% of IFD, 
and 87% of SBA.  Higher MMR locations have historically had much lower coverage of these services, 
particularly IFD and SBA, and increasing access to them will require sustained focus.  
Quality of care must also be a focus as coverage of family planning services, ANC, IFD, SBA, EmOC, and 
post-natal care increase, because the existence of these programs by themselves is not sufficient to 570 
ensure that women are receiving the care they need during pregnancy and the post-partum period48. 
Care should be integrated and not be focused on single vertical interventions49. Family planning services 
should be longitudinal and include provision of comprehensive sex education, multiple modes of 
modern contraception, and access to safe abortion50. High-quality ANC should reflect appropriate 
utilization of services, good communication between patient and provider, and reliable screening and 575 
treatment for infectious diseases, (e.g., sexually transmitted infections), chronic conditions (e.g., blood 
disorders, obesity, substance abuse, renal dysfunction, rheumatic or other heart disease) and pregnancy 
abnormalities (e.g., anemia, nutritional deficiencies, blood pressure, glucose, urine protein, fetal growth 
anomalies)51,52. IFD and SBA services must be adequately staffed to meet demand and, because not all 
major complications of pregnancy are avoidable or easily predictable, women need to have ready access 580 
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to well-functioning basic and comprehensive emergency obstetric care (EmOC) services. These services 
must be appropriately distributed to meet demand53 and be staffed by sufficient numbers of trained 
midwives, nurses, anesthesia and obstetrical providers to meet demand, including on nights and 
weekends. Health professionals in EmOC facilities also need to have appropriate equipment including 
medications, access to blood transfusion materials, and intensive care services to help prevent 585 
complications from leading to death54,55. Post-natal care should focus on detection and treatment of 
those conditions known to be more common in the postpartum and late maternal period, including 
cardiomyopathy, pulmonary embolism, and renal complications56,57. In countries with generalized HIV 
epidemics, AIDS-related deaths have also been observed to commonly occur 42 days or more after 
pregnancy ends, and care efforts for HIV-positive mothers should focus on ensuring uninterrupted 590 
antiretroviral treatment58,59. 
Late maternal death statistics need to be improved. Maternal mortality surveillance studies such as 
confidential enquiry (CE) have revealed that late maternal death is non-trivial in even low-resource 
settings35,60 and may account for up to 40% of maternal deaths in high-income settings61. A 
contemporary linkage study in Mexico found that 18% of maternal deaths are missed when the 595 
definition is truncated at 42 days postpartum62. As immediate mortality continues to decrease as a 
result of improved antenatal, obstetric, and postpartum care, it is therefore increasingly likely that the 
proportion of late maternal deaths will continue to increase. Despite knowledge of its importance, only 
a minority of countries using ICD-10 reliably code late maternal deaths. This is especially egregious as 
many of the same countries who have completed multiple CEs also have not recorded a single late 600 
maternal death in their official statistics. Denmark, Ireland, Finland, and the United Kingdom all fall into 
this category. Australia, France, and South Africa likewise completed multiple CEs and have recorded a 
total of eight maternal deaths combined in the entirety of their official statistics. This is the exact inverse 
of the United States where no nationally comprehensive CEs have been completed (although some 
states have established maternal mortality review boards). The US has high MMR for a high-SDI 605 
country—and is one of the few where it is increasing – but following the lead of Mexico and much of 
Latin America, it is also one of the only countries that has proactively improved its civil registration 
system with addition of a pregnancy checkbox on the standard death certificate63, so it is possible that 
at least a portion of the increase is related to enhanced case ascertainment63. The US should learn from 
the experiences of other countries and consider implementing regular, comprehensive CEs into drivers 610 
of maternal mortality. Other countries and subnational locations should follow the lead of the countries 
of the Americas by adding pregnancy checkboxes to their official death certificates and also ensuring 
that cooperation between their national statistics office and CE committees maximizes data quality.  
Comparison to WHO maternal mortality estimates  
The WHO also recently published a set of maternal mortality estimates for 1990 to 201564,65 as part of its 615 
collaboration with the UN Maternal Mortality Estimation Inter-Agency Group (MMEIG). MMEIG 2015 
global results again show a steep decline in maternal mortality from 1995 to 2005, and some 
deceleration in the period 2005 to 2015 when maternal and newborn health DAH increased rapidly. GBD 
2015 shows relatively little progress in the 1990s, but acceleration in MMR declines particularly after 
2005. We have previously discussed some of the important differences between the analytic approaches 620 
used by GBD and MMEIG66. These included differences in dataset content, data processing methods, all-
cause mortality, model specification, quantification of uncertainty, the use of CoDCorrect to ensure 
consistency between all specific causes of death, and the fact that MMEIG 2013 combined three 
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separate estimation methods for different categories of countries whereas GBD uses a single approach 
for all countries.  625 
MMEIG has made some important modifications to their analysis since 2013, most notably 
implementation of a Bayesian approach that combines all countries into a single model to estimate 
maternal mortality cause fractions (the proportion of all deaths in the population that are due to 
maternal causes). These changes are especially apparent in estimates for a number of countries 
including South Korea, Malaysia, Sri Lanka, Kiribati, Cyprus, Finland, Georgia, Mongolia, Romania, 630 
Estonia, Latvia, Russia, and Bosnia and Herzegovina. Figures comparing MMEIG 2015 and GBD 2015 data 
inputs and results for each country are contained in the appendix. The correlation in MMR between 
MMEIG 2015 and GBD 2015 estimates is now 0.85 over the entire time period from 1990 to 2015; this 
compares to a correlation in MMR between GBD 2013 and MMEIG 2013 of 0.77. If we limit the 
comparison to 2005 to 2015, correlation in MMR increases to 0.89. 635 
Overall drivers of differences 
Figure 11 compares the country-specific trends from 1990 to 2015 between the two analyses. Whereas 
GBD 2015 identified only ten countries as likely having achieved MDG 5, MMEIG 2015 found a total of 
18 achieved the MDG 5 target. Because both groups use the same set of live births estimates from the 
UN Population Division, with the exception that GBD 2015 estimated maternal mortality for the entire 640 
age range from 10 to 54 years, differences in fertility are unlikely to be a major driver of differences 
between the two results. Drivers of differences can thus be best summarized as being due to differences 
in maternal cause fraction estimates or differences in all-cause mortality numbers as shown in Figure 12. 
Global MMR estimates in 1990 were much higher in the MMEIG 2015 analysis, driven largely by higher 
estimates of maternal cause fraction in sub-Saharan Africa, South Asia, Central Asia, central Latin 645 
America, and North Africa and the Middle East. MMEIG 2015 all-cause mortality estimates for 1990 
were also higher in many of these same regions as well as in Tropical and Andean Latin America, all of 
which led to higher MMR estimates than those produced by GBD 2015. Of note, GBD 2015 maternal 
cause fraction estimates were higher in most high-income regions, central Europe, and Oceania. In 
contrast, our decomposition of the drivers of differences in 2015 estimates show that differences in 650 
maternal cause fraction and all-cause mortality estimates narrowed in South Asia, central Asia, and 
much of sub-Saharan Africa, which has on aggregate led to broad agreement in global MMR figures for 
2015. GBD 2015 estimates of maternal cause fraction estimates remain notably higher in high-income 
North America, Western Europe, and Oceania, although it is likely that much of this is driven by MMEIG 
2015 exclusion of late maternal mortality.     655 
Comparison of data sources as a driver of divergent maternal cause-fraction estimates 
As shown in Table 1, the total number of sources used by MMEIG 2015 was 203 and by GBD 2015 was 
599. Appendix Table 3 shows all country-specific sources by type used in each analysis. For a number of 
populous countries—including China, Ethiopia, Indonesia, and India—differences in maternal cause 
fraction estimates are largely driven by dataset content. MMEIG 2015 did not include data from Medical 660 
Certification of Cause of Death (MCCD)67 or the Survey of Causes of Death (SCD)68 from India, several 
years of census and verbal autopsy data from Indonesia and Ethiopia, and maternal mortality 
surveillance data from China. MMEIG 2015 similarly did not include VR data from Iran and Dominican 
Republic or sibling history from Jordan, all of which led to very different estimates of levels and trends of 
maternal mortality in those countries. In total, 396 sources were excluded by MMEIG 2015. In many 665 
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cases the MMEIG 2015 documentation does not describe reasons for not including these data. In future 
iterations of both the GBD and MMEIG estimation, the groups should both work more closely to ensure 
relevant data sources are included in both analyses.  
Comparison of data processing methods 
Differences in processing methods of sibling history data are important, especially for countries in sub-670 
Saharan Africa. The nine countries without maternal mortality data in the GBD 2015 analysis were 
Andorra, Angola, Equatorial Guinea, the Federated States of Micronesia, Marshall Islands, Samoa, 
Solomon Islands, Somalia, and Vanuatu. MMEIG 2015 had no data for 23 GBD 2015 countries or 
territories, including Angola, Djibouti, Federated States of Micronesia, Guinea Bissau, North Korea, 
Palestine, Papua New Guinea, Samoa, Solomon Islands, Somalia, Tonga, and Vanuatu. They did not 675 
generate estimates at all for American Samoa, Andorra, Antigua and Barbuda, Bermuda, Dominica, 
Greenland, Guam, Marshall Islands, Seychelles, Taiwan, and US Virgin Islands. 
GBD 2015 utilized single-year sibling history survival data from each source, applied Gakidou-King 
weights to adjust for survivor bias, corrected for incidental HIV deaths using country-year-age-specific 
information on the PAF of HIV to maternal death, and employed Bayesian noise-reduction algorithms to 680 
help reduce stochastic variability in data. On aggregate, this approach maximizes capture of underlying 
information on levels and trends of pregnancy-related mortality in health surveys. MMEIG 2015 
combined all data from each survey and assigned them to the midpoint year of the recall period. They 
then uniformly applied a correction factor to reduce every datum by 10% or 15%, depending on the 
geography. The resulting MMEIG dataset is relatively sparse in some locations, and estimates are driven 685 
by regression coefficients. Examples can be seen in Democratic Republic of the Congo, Saudi Arabia, 
Ghana, and Ethiopia (see Appendix Figure 3). We would encourage MMEIG to consider using single-year 
sibling history data in their future analyses, as this difference in data processing may be driving 
divergence in trends from the early part of the MDG period, especially in sub-Saharan Africa.  
Another important dataset difference is in the method used for processing and adjustment of VR data. 690 
GBD uses a standardised approach for all causes of death, empirically analysing every location’s single-
year VR quality to guide dynamic adjustments to raw data (Figure 13). In past studies, MMEIG applied a 
default correction factor of 1.5 to all VR data. That method was modified in two ways in 2015. First, 
correction factors for VR were adjusted to match the deaths in published surveillance studies for those 
countries that had completed them. Second, MMEIG 2015 reclassified selected recent years of VR data 695 
as special studies. These reclassified years were not subjected to the 1.5 correction factor, but earlier 
years were. This reclassification resulted in estimates showing faster declines in the MMR than are 
supported by raw data. These seven countries where the MMEIG results are affected by the selective VR 
reclassification are Brazil, Costa Rica, Cuba, Ecuador, Guatemala, Kazakhstan, Mexico, and Uruguay. The 
criteria used for reclassification of VR as special studies are not clearly documented, and it is unclear if 700 
these criteria have been objectively applied to all country-years of VR.  
Comparison of modeling methods 
MMEIG implemented a Bayesian approach to estimating maternal mortality for the first time in their 
2015 estimates, which dramatically improved their model fit in countries with long time series of data. 
However, the base MMEIG model still relied on a simple linear mixed-effects model with only three 705 
covariates—gross domestic product (GDP), general fertility rate (GFR), and skilled attendance at birth 
(SAB)—and country random effects.  In contrast, the GBD 2015 used four families of statistical models 
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and using 15 different covariates to develop ensemble models that were chosen based on a robust out-
of-sample validity testing. MMEIG models were developed for the aggregate age range of 15 to 49 years, 
while the GBD 2015 estimates were generated separately for nine different 5-year age bands ranging 710 
from 10 to 54 years. The latter approach has the noted advantage of being able to automatically adjust 
for compositional bias if the age structure of the sample population is different than the general 
population. It also facilitates insight into potentially divergent age trends in maternal mortality within 
individual populations, matching them with corresponding shifts in age-specific fertility. Such an 
approach is crucial to singling out, for example, the contribution of adolescent fertility to overall 715 
maternal mortality levels and trends in maternal mortality. We therefore believe age-specific maternal 
mortality estimates, covering the entire reproductive age range, should be standard practice.   
All-cause mortality estimates 
While recognizing the potential caveats of adult mortality rates estimated using sibling survival, we 
made important improvements in GBD 2015 in accounting for selection bias and recall bias. We 720 
incorporated the uncertainty around adult mortality rate into our all-cause mortality estimation process 
for countries affected by HIV/AIDS in the sub-Saharan Africa regions. We did this by using single-year 
data on adult mortality rate from sibling survival modules—instead of pooled data for five-year 
periods—and the crude death rate due to HIV/AIDS into the Space-Time Gaussian Process Regression 
that generates adult mortality rate estimates. This approach helped reconciliation between all-cause 725 
mortality estimates based on demographic sources and the HIV-specific mortality estimates using EPP-
Spectrum, thus allowing us to better capture levels and trends of mortality in adult women, especially in 
western and central sub-Saharan Africa. In contrast, mortality estimates from WPP 2015 do not 
incorporate all available data, do not explicitly reconcile HIV-related and background mortality 
estimates, and for many countries are largely based on a tabular model life table system derived from 730 
that age pattern of mortality from countries in the 1950s and 1960s and a single entry parameter, the 
under-5 mortality rate. Such a system is likely to misrepresent the changing relationship between 
mortality in child age groups and adult age groups69 and, as we see from WPP 2015 all-cause mortality 
estimates in the 1990s, may overestimate mortality in western and central sub-Saharan Africa70. 
Quantification of uncertainty 735 
The GBD approach to quantification of uncertainty assumes that uncertainty is uncorrelated in all 
locations. MMEIG has in the past assumed uncertainty is 50% correlated and 50% uncorrelated. This has 
led to very large uncertainty intervals in many countries and at the global level in past reports. MMEIG 
2015 has implemented a more rigorous statistical approach to estimating uncertainty but has chosen 
the non-standard step of reporting only 80% uncertainty intervals, despite the general global health 740 
practice of reporting 95% UIs. The rationale provided for this decision was that 95% UIs cannot be 
reliably interpreted, although why 80% intervals are more interpretable is unclear. In the interests of 
transparency and comparability to other analyses such as the GBD, we hope that in future estimates 
MMEIG will provide 95% uncertainty intervals along with other narrower intervals.  
Limitations 745 
This analysis, like many before it, has a number of limitations. First, despite continued increase in the 
size and breadth of our data sources, there are still several countries and territories from which we have 
no data on maternal mortality. In a number of other locations, especially low-SDI geographies, we 
continue to rely on data reporting aggregate pregnancy-related deaths from surveys and censuses. 
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Unlike VA and VR sources, survey and census data sources do not differentiate between maternal and 750 
non-maternal (incidental) deaths during pregnancy. The degree to which underreporting due to survival 
and recall bias offsets overreporting due to inclusion of incidental deaths is unclear and is further reason 
to advocate for improved data collection efforts. Second, while we report results on the entire period 
from 1990 to 2015, because of large lag times in release of data we have not been able to include any 
data from 2015 and data from only 13 countries from 2014. Final 2015 results are thus based on recent 755 
historical data and model results. Third, our CODEm models have limited ability to capture non-
stochastic rapid increases and decreases that may occur as a result of epidemics such as Ebola and H1N1 
influenza71,72, armed conflicts73, or other events. Fourth, this report has examined nine specific etiologic 
categories of maternal death, but this classification system is certainly not exhaustive. We have not 
evaluated the contributions of some important chronic conditions known to increase risk to pregnant 760 
women such as obesity, diabetes, heart disease, hemoglobinopathies such as sickle cell disease, chronic 
kidney disease, and chronic hypertension, or specific risk factors that may contribute to mortality. Our 
evaluation of ectopic pregnancy, abortion, and miscarriage together limits the ability to specifically 
quantify the burden of unsafe abortion. We likewise have not disaggregated the other direct obstetric 
complications category to quantify the relative importance of anesthesia complications, 765 
cardiomyopathy, and pulmonary embolism, all of which are known to be important contributors to 
maternal mortality in many settings. Continuing to improve on the specificity of our analysis of the 
underlying etiology of maternal death will be expected to improve the clinical utility of GBD estimates. 
Fifth, while the GBD approach has the ability to provide excellent detail on geographic and temporal 
trends in maternal mortality, it has limited ability to explore subpopulations which are not 770 
geographically based, including indigenous populations or other high-risk groups who may have higher 
MMR due to cultural, religious, or other differences.  
Conclusions 
A shift from a relative target of percent reduction in MDGs to an absolute threshold target of an MMR of 
70 in the SDGs has important ramifications. It will emphasise countries with high maternal mortality 775 
rates over those that have already achieved the goal. Such emphasis may be beneficial in that it should 
help focus additional international attention and resources on those countries who have the farthest 
distance to go. On the other hand, preemptive “achievement” of SDG 3.1 has the potential to sap 
political and financial investment in reproductive health in countries that still have significant numbers 
of preventable maternal deaths, especially when continued progress is likely to depend largely on 780 
improvements in overall health systems performance74–78. One approach to mitigate this risk would be 
to promote SDG 3.1 not only as a threshold goal for nations on aggregate, but also a target for all sub-
populations within each. This will require all stakeholders to make disaggregated data and information 
on women’s, children’s and adolescents’ health publicly available5. Furthermore, as the global 
community pursues SDG 3.1, it will be important to monitor and report on all aspects of reproductive 785 
health care as outlined in SDG 3.75. This will require the international community to pay heed to the 
intricately related issues of immigration, armed conflicts, epidemics and pandemics, environment, 
economic instability, and gender equality, all of which can have significant effects on availability and 
quality of reproductive health services and women’s willingness to seek them. 
Global progress in reducing maternal mortality has been accelerating in the past 15 years, but there is 790 
still significant work left to do. More than 250,000 women died during or following pregnancy in 2015, 
the vast majority of which were preventable deaths. Each woman that died left children, widowers, 
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family, and their communities behind. The quantitative effect of MDG 5 is difficult to measure, but it is 
even harder to dispute the notion that it has united the international community in striving to decrease 
maternal mortality. With the ratification of SDG 3.1 and SDG 3.7, relevant stakeholders need to make 795 
informed decisions about how to prioritise actions needed to bring about continued progress, and they 
can only do that with better data. As we continue on the path toward 2030, necessary and urgent steps 
will include rapid improvement in cause of death data collection systems and data dissemination 
coupled with more effective and widespread action and policies to promote education of girls and 
women, provide them comprehensive family planning services, and ensure that each and every woman 800 
has access to the types of reproductive care they need to survive – and thrive.  
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